With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology ...
Immunotherapy has revolutionized cancer treatment, with immune checkpoint inhibitors (ICIs) playing a pivotal role. However, current ICIs, primarily monoclonal antibodies, face significant challenges ...